Analysis of anxiety and depression in patients undergoing radiotherapy during COVID-19 epidemic period
10.3760/cma.j.cn113030-20200417-00188
- VernacularTitle:2019新型冠状病毒病（COVID-19）疫情期间放疗患者焦虑抑郁状况分析
- Author:
Jiabin MA
1
;
Hongnan ZHEN
;
Hui GUAN
;
Zhikai LIU
;
Jing SHEN
;
Wenhui WANG
;
Zheng MIAO
;
Junfang YAN
;
Qingyu MENG
;
Ke HU
;
Fuquan ZHANG
Author Information
1. 中国医学科学院北京协和医学院北京协和医院放疗科 100730
- From:
Chinese Journal of Radiation Oncology
2020;29(8):615-618
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the anxiety and depression of cancer patients undergoing radiotherapy during the epidemic of COVID-19.Methods:By using self-rating anxiety scale and self-rating depression scale, a cross-sectional survey was conducted during the COVID-19 epidemic period.Results:During the COVID-19 epidemic period, the incidence of anxiety and depression in cancer patients undergoing radiotherapy was 15.8% and 27.7% respectively, of which 12.9% suffered from both anxiety and depression. The average scores of anxiety and depression were 49.4(25/76) and 46.4(25/83), respectively, which were higher than those of the domestic norm. Age is a contributing factor for anxiety, and patients living in urban are more likely to experience depression.Conclusions:The prevalence of anxiety and depression of cancer patients undergoing radiotherapy are higher than healthy people during the COVID-19 outbreak. We should pay more attention to the psychological states of the cancer patients.
